Nanjing Dorra Pharmaceutical Technology Co.,Ltd.

Dorrapharma is engaged in R&D, manufacture and market of intermediates, APIs (Active Pharmaceutical Ingredients) and formulation. We stick to raise the value both for the company and customer, and strive for serving for the society and caring of the others. We devote ourselves completely to the technology innovation and brand build and make every effort to foster the core competence for the company.

The manufacturing sites are approved by Chinese NMPA, Japan PMDA, FDA,EU authorities and etc. The total reactor capacity is 2,000,000L and the production output for intermediates/APIs is about 5,500 tons per year with the 8000 square meters of finishing area classified as class D. The therapeutic areas cover anti-infection, anti-virus, digestive system, treatment, cardiovascular system and etc. The services supplied are included in material sourcing, route selection, process & analytical development, custom synthesis of APIs and formulation and etc.

We are consecutive to concern about the public and repay the society with strong responsibility and social mission along with development of the company. We are committed to make great performance and contribute to the happiness of human life based on integrity and innovation.